Top compounds associated with response to ZNF285


Feature Type Standardized
Nominal ANOVA
mRNA fingolimod CTRPv2 pan-cancer AAC -0.058 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC -0.089 0.1
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC 0.086 0.1
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.052 0.1
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.055 0.1
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.081 0.1
mRNA alisertib CTRPv2 pan-cancer AAC -0.05 0.1
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.058 0.1
Download CSV